Indeed, our results revealed treatment of NSCLC cells with NAT-F resulted in a drop of MMP in a concentration-dependent manner and significantly elevated the expression of cytochrome c in the cytoplasm. The gene discussed is CYCS; the disease is non-small cell lung carcinoma.